Summary
Eleven folic acid sensitive fragile sites (3p14, 7p13, 7q31.1, 7q32, 9q32, 11p13, 14q23, 15q22, 16q23, Xp22.2, Xq22) were detected in one individual, eight of them previously unknown. These sites seem to bear each its specific sensitivity to folic acid deficiency. Six of the sites were observed simultaneously on both homologous chromosomes in at least one cell. Each of these 11 sites was also found in at least one among 12 individuals further examined. Some of these individuals showed six of these 11 sites. The fragile site 3p14 was detected in all individuals examined. The homologous sites 3p14 of one individual differed from each other in their frequency of lesions induced by methotrexate as well as fluorodeoxyuridine. This observation suggests that folic acid sensitivity is a property inherent in the chromatin of an individual chromosome at the site involved in fragility. This property seems to be responsible for the nonrandom fragility at that site and also for the individual sensitivity of each chromosomal site.
Similar content being viewed by others
References
Benedict WF, Banerjee A, Gardner A, Jones PA (1977) Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T)C1-3 cells by cancer chemotherapeutic agents. Cancer Res 37:2202–2208
Das KC, Herbert V (1978) The lymphocyte as a marker of past nutritional status: persistence of abnormal lymphocyte deoxyuridine (dU) suppression test and chromosomes in patients with past deficiency of folate and vitamin B12. Br J Haematol 38:219–233
de la Chapelle A, Berger R (1984) Los Angeles Conference 1983. Seventh international workshop on human gene mapping. Report of the committee on chromosomal rearrangements in neoplasia and on fragile sites. Cytogenet Cell Genet 37:274–311
Glover TW (1981) FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition. Am J Hum Genet 33:234–242
Goulian M, Bleile B, Tseng BY (1980) Methotrexate-induced misincorporation of uracil into DNA. Proc Natl Acad Sci USA 77:1956–1960
Hecht F, Jacky PB, Sutherland GR (1982) The fragile X chromosome: current methods. Am J Med Genet 11:489–495
ISCN (1978) An international system for human cytogenetic nomenclature (1978). Report of the standing committee on human cytogenetic nomenclature. Cytogenet Cell Genet 21:309–409
Jennings M, Hall JG, Hoehn H (1980) Significance of phenotypic and chromosomal abnormalities in X-linked mental retardation (Martin-Bell or Renpenning syndrome). Am J Med Genet 7:417–432
Krumdieck CL, Howard-Peebles PN (1983) On the nature of folicacid-sensitive fragile sites in human chromosomes: an hypothesis. Am J Med Genet 16:23–28
Markkanen A, Heinonen K, Knuutila S, de la Chapelle A (1982) Methotrexate-induced increase in gap formation in human chromosome band 3p14. Hereditas 96:317–319
Menzies RC, Crossen PE, Fitzgerald PH, Gunz FW (1966) Cytogenetic and cytochemical studies on marrow cells in B12 and folate deficiency. Blood 28:581–594
Shabtai F, Klar D, Nissimov R, Vardimon D, Hart J, Halbrecht I (1983) A new familial “fragile site” on chromosome 16 (q23–24). Cytogenetic and clinical considerations. Hum Genet 64:273–276
Sutherland GR (1979) Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. Am J Hum Genet 31:125–135
Sutherland GR, Jacky PB, Baker E, Manuel A (1983) Heritable fragile sites on human chromosomes. X. New folate-sensitive fragile sites: 6p23, 9p21, 9q32, and 11q23. Am J Hum Genet 35:432–437
Vorhees JJ, Janzen MK, Harrell ER, Chakrabarti SG (1969) Cytogenetic evaluation of methotrexate-treated psoriatic patients. Arch Dermatol 100:269–274
Wegner RD (1983) A new inducible fragile site on chromosome 3(p14.2) in human lymphocytes. Hum Genet 63:297–298
Welch JP, Winsor EJT, Camfield PR, Raftus RA (1982) Occurrence and possible significance of a “new” fragile site on chromosome 3. Am J Hum Genet 34:150A
Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136–142
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barbi, G., Steinbach, P. & Vogel, W. Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sites. Hum Genet 68, 290–294 (1984). https://doi.org/10.1007/BF00292586
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00292586